<ѻý>Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLLѻý> Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
<ѻý>New Standard of Care in High-Risk Acute Promyelocytic Leukemia?ѻý> All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
<ѻý>New Clues to Origin of T-Cell Lymphoma After CAR-T Therapyѻý> Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
<ѻý>Telomerase Inhibitor Approved for MDS-Related Anemiaѻý> Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
<ѻý>'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trialѻý> News, features, and commentary about cancer-related issues Jun 06, 2024
<ѻý>Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brainsѻý> Health news and commentary gathered by ѻý staff Jun 05, 2024
<ѻý>STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CMLѻý> The benefit-risk profile could change the treatment paradigm in CML, expert says May 31, 2024
<ѻý>Ignoring Colonoscopy Advice; Inflamed Tongue, Then Cancer; Acupuncture for Dry Mouthѻý> News, features, and commentary about cancer-related issues May 24, 2024
<ѻý>Ending Oncology's Toxic Relationship With High Chemotherapy Dosesѻý> Optimizing doses can improve patient outcomes and lower costs May 10, 2024
<ѻý>Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Showѻý> Study finds survival is comparable to that seen in younger patients in VIALE-A trial May 09, 2024
<ѻý>Fresh and Frozen Embryo Transfers May Increase Risk of Childhood Leukemiaѻý> However, overall cancer risk was not higher after fertility treatments vs natural conception May 02, 2024
<ѻý>High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLLѻý> Undetectable disease rate over 90%, ctDNA also promising for earlier detection of recurrence Apr 24, 2024
<ѻý>CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancersѻý> "All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease Apr 24, 2024
<ѻý>Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugsѻý> However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
<ѻý>1,000 Paper Cranes Can Bring Our Patients One Step Closer to Healingѻý> We must remind our patients to hold on to hope Apr 11, 2024
<ѻý>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendationsѻý> News, features, and commentary about cancer-related issues Mar 29, 2024
<ѻý>Breastfeeding Tied to Reduced Childhood Leukemia Riskѻý> Lower pediatric ALL risk in Danish study when mothers exclusively breastfed for 3 months or more Mar 27, 2024
<ѻý>FDA Approves New Frontline Regimen for Aggressive ALLѻý> Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases Mar 22, 2024
<ѻý>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancerѻý> News, features, and commentary about cancer-related issues Mar 22, 2024
<ѻý>EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Riskѻý> Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
<ѻý>FDA Approves First CAR-T for Chronic Lymphocytic Leukemiaѻý> Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
<ѻý>FDA Panel Endorses Imetelstat for MDS-Related Anemiaѻý> By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
<ѻý>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'ѻý> News, features, and commentary about cancer-related issues Mar 14, 2024
<ѻý>FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemiaѻý> Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
<ѻý>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertuѻý> News, features, and commentary about cancer-related issues Mar 07, 2024
<ѻý>All-Oral AML Regimen Shows Promise for Older, Unfit Patientsѻý> Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease Mar 05, 2024
<ѻý>Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Updateѻý> The EPA is set to take action after public outcry Mar 03, 2024
<ѻý>New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Resultsѻý> News, features, and commentary about cancer-related issues Mar 01, 2024
<ѻý>Oldest Patient 'Cured' of HIV Still in Remission 5 Years After Transplant for AMLѻý> But it's unlikely stem cell transplants will ever be large-scale cure for HIV, says expert Feb 14, 2024
<ѻý>FLT3 Inhibitor Highly Active in Newly Diagnosed Acute Myeloid Leukemiaѻý> Complete response rate of 86%, median event-free survival approaching 4 years with crenolanib Feb 13, 2024
<ѻý>No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No Moreѻý> News, features, and commentary about cancer-related issues Feb 09, 2024
<ѻý>All-Oral Therapy Promising in Higher-Risk MDS, CMMLѻý> In small trial, overall response rate was 95% Feb 05, 2024
<ѻý>Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Saysѻý> Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
<ѻý>When a Revolutionary Cancer Treatment Causes Cancerѻý> The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
<ѻý>CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warningѻý> Post-treatment cases grow to 22 since products' initial approvals Jan 24, 2024
<ѻý>FDA Calls for New Boxed Warning on All CAR-T Productsѻý> Most serious warning would alert patients, providers on potential risk for secondary malignancies Jan 23, 2024
<ѻý>Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancerѻý> News, features, and commentary about cancer-related issues Jan 19, 2024
<ѻý>Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivorsѻý> While safe, the results do not support use of the drug in anthracycline-exposed survivors Jan 10, 2024
<ѻý>Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemiaѻý> Investigational drug revumenib now under review at FDA for KMT2A-rearranged disease Dec 12, 2023
<ѻý>MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemiaѻý> No advantage for MRD-negative patients in first remission after induction, regardless of FLT3 ITD Dec 11, 2023